Ostex Seeks Distributor For Point-Of-Care Bone Marker; Launches Serum Test
This article was originally published in The Gray Sheet
Executive Summary
Ostex is negotiating an agreement with potential distributors for its point-of-care Osteomark NTx bone resorption urine test for use in physician offices. A 510(k) was submitted to FDA in December.